Caseware UK (AP4) 2025.0.111 2025.0.111 2026-03-312026-03-31222025-04-01falseNo description of principal activityfalseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false SC568266 2025-04-01 2026-03-31 SC568266 2024-04-01 2025-03-31 SC568266 2026-03-31 SC568266 2025-03-31 SC568266 c:Director1 2025-04-01 2026-03-31 SC568266 d:CurrentFinancialInstruments 2026-03-31 SC568266 d:CurrentFinancialInstruments 2025-03-31 SC568266 c:Micro-entities 2025-04-01 2026-03-31 SC568266 c:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 SC568266 c:FullAccounts 2025-04-01 2026-03-31 SC568266 c:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 SC568266 e:PoundSterling 2025-04-01 2026-03-31 iso4217:GBP xbrli:pure

Registered number: SC568266










CAESAR MEDICAL LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2026

 
CAESAR MEDICAL LIMITED
REGISTERED NUMBER: SC568266

BALANCE SHEET
AS AT 31 MARCH 2026

2026
2025
£
£


Current assets
77,071
54,457

Creditors: amounts falling due within one year
(19,065)
(16,579)

Net current assets
 
 
58,006
 
 
37,878

Total assets less current liabilities
58,006
37,878


Net assets
58,006
37,878



Capital and reserves
58,006
37,878


Notes


General information

Caesar Medical Limited is a private company limited by shares incorporated in Scotland. The registered office is 6 St Colme Street, Edinburgh, EH3 6AD.


Average number of employees

The average monthly number of employees, including directors, during the year was 2 (2025 - 2).

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 1 September 2026.




................................................
Dr Claire Grace Caesar
Director

 
Page 1